Use of second-line therapies for management of massive primary postpartum hemorrhage

Int J Gynaecol Obstet. 2013 Sep;122(3):238-43. doi: 10.1016/j.ijgo.2013.03.027. Epub 2013 Jun 24.

Abstract

Objective: To determine rates of use and success of second-line therapies for massive primary postpartum hemorrhage (PPH).

Methods: A retrospective cohort study was conducted among 91 women who gave birth at Kwong Wah Hospital, Hong Kong, between January 1, 2006, and December 31, 2011. Inclusion criteria were gestational age of at least 24 weeks and massive PPH (defined as blood loss ≥1500 mL within 24 hours after birth). Second-line therapies assessed were uterine compression sutures, uterine artery embolization, and balloon tamponade after failure of uterine massage and uterotonic agents to stop bleeding.

Results: The rate of massive PPH was 2.65 per 1000 births. Second-line therapies were used among 42 women with PPH, equivalent to a rate of 1.23 per 1000 births. Only 21.4% of the women who received second-line therapies required rescue hysterectomy. A rising trend was observed for the use of second-line therapies, whereas the incidence of rescue hysterectomy and estimated blood loss were found to concomitantly decrease.

Conclusion: Increasing use of second-line therapies among women with massive PPH was associated with a decreasing trend for rescue hysterectomy. Obstetricians should, therefore, consider all available interventions to stop PPH, including early use of second-line options.

Keywords: Balloon tamponade; Hysterectomy; Primary postpartum hemorrhage; Second-line therapy; Uterine arterial embolization; Uterine compression suture.

MeSH terms

  • Adult
  • Cohort Studies
  • Female
  • Hong Kong
  • Humans
  • Hysterectomy / statistics & numerical data
  • Massage / methods
  • Oxytocics / therapeutic use
  • Postpartum Hemorrhage / therapy*
  • Pregnancy
  • Retrospective Studies
  • Suture Techniques*
  • Treatment Outcome
  • Uterine Artery Embolization / methods*
  • Uterine Balloon Tamponade / methods*

Substances

  • Oxytocics